Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...
Silver (XAG) Forecast: Bullish Price Prediction as Physical Squeeze Fuels Silver RallySun, 12 Oct 2025 07:22:11 GMT Bitcoin (BTC) Price Forecast: Trade War, Fed Bets, and ETF Inflows Set the Tone for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback